Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing therapy for Candida infections.

Elliott Geoffrey Playford1, Tania C Sorrell

  • 1Infection Management Services, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia. geoffrey_playford@health.qld.gov.au

Seminars in Respiratory and Critical Care Medicine
|December 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reaffirming the importance of nomenclature stability for <i>Candida auris</i> and its associated disease of candidiasis.

Journal of clinical microbiology·2025
Same author

Reconsidering the blood-brain barrier: histopathology and microanatomy of cryptococcal CNS infection.

Microbiology and molecular biology reviews : MMBR·2025
Same author

Impact of opinion dynamics on recurrent pandemic waves: balancing risk aversion and peer pressure.

Interface focus·2025
Same author

Multi-scale phylodynamic modelling of rapid punctuated pathogen evolution.

PLoS computational biology·2025
Same author

Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology.

Journal of clinical microbiology·2024
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Invasive candidiasis in ICU patients is rising, with drug resistance complicating treatment. New antifungal options exist, but early diagnosis and targeted therapy are crucial for better outcomes.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Mycology

Background:

  • Invasive candidiasis presents a growing challenge in intensive care units (ICUs), affecting vulnerable patients.
  • Rising incidence of fluconazole-resistant Candida species complicates treatment strategies.
  • Despite supportive care advances, outcomes for invasive candidiasis remain poor.

Purpose of the Study:

  • To review the current landscape of invasive candidiasis in ICUs.
  • To discuss challenges in managing evolving epidemiological trends and antifungal resistance.
  • To highlight the need for improved diagnostic markers and optimized therapeutic approaches.

Main Methods:

  • Review of current literature on invasive candidiasis epidemiology and treatment.

Related Experiment Videos

  • Analysis of emerging antifungal agents and their properties.
  • Discussion of factors influencing antifungal therapy optimization.

    • Main Results:

    • Newer antifungal agents (voriconazole, echinocandins, lipid amphotericin B) offer improved safety and efficacy.
    • Optimizing therapy requires careful consideration of drug properties, cost, patient status, and resistance likelihood.
    • Early diagnosis and intervention are critical for favorable outcomes.

    Conclusions:

    • Effective management of invasive candidiasis necessitates a personalized approach considering multiple clinical and microbiological factors.
    • Accurate early diagnostic markers for invasive candidiasis are urgently needed to guide timely antifungal interventions.
    • Continued research into early detection and treatment strategies is essential for improving patient outcomes in ICUs.